Well said,
in addition for some tumours, identifying an antigen that is only expressed on the tumour cell and not on healthy tissue is a significant obstacle
to be overcome. Jeffrey Molldrem seems to specialise in this area.
PTX + MD Anderson collaboration means multiple opportunities that the PTX platform will be used as the treatment platform used to treat many, many different cancers.
Well said,in addition for some tumours, identifying an antigen...
Add PTX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $41.87M | |||
| Open | High | Low | Value | Volume |
| 5.4¢ | 5.4¢ | 5.0¢ | $44.20K | 858.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 97252 | 5.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.2¢ | 97976 | 2 |
View Market Depth
| Last trade - 16.10pm 30/04/2024 (20 minute delay) ? |
|
|||||
|
Last
5.0¢ |
Change
0.000 ( 3.85 %) |
||||
| Open | High | Low | Volume | ||
| 5.3¢ | 5.3¢ | 5.0¢ | 119475 | ||
| Last updated 15.32pm 30/04/2024 ? | |||||
| PTX (ASX) Chart |